FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Lidocaine | 9 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Qualgen LLC | 034474862 | 69761-187 | 69761-187-01 | Testosterone | 87.5 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-125 | 69761-125-01 | Testosterone | 25 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-110 | 69761-110-01 | Testosterone | 100 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-150 | 69761-150-01 | Testosterone | 50 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-120 | 69761-120-01 | Testosterone | 200 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-112 | 69761-112-01 | Testosterone | 12.5 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-137 | 69761-137-01 | Testosterone | 37.5 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-222 | 69761-222-01 | Testosterone; Anastrozole | 200 mg; 20 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-006 | 69761-006-01 | Estradiol | 6 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-010 | 69761-010-01 | Estradiol | 10 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-015 | 69761-015-01 | Estradiol | 15 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-020 | 69761-020-01 | Estradiol | 20 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-022 | 69761-022-01 | Estradiol | 22 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-025 | 69761-025-01 | Estradiol | 25 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-018 | 69761-018-01 | Estradiol | 18 mg | 2019-2 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-012 | 69761-012-01 | Estradiol | 12.5 mg | 2019-2 | valid | 2026-11-14 | |
| QuVa Pharma | 079937015 | Methadone Hydrochloride | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Methohexital Sodium | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Midazolam | 30 mg/30 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Midazolam | 50 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Midazolam Hydrochloride | 55 mg/55 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 30 mg/30 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 4 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 100 mg/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 50 mg/50 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 30 mg/30 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 1 mg/2 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 100 mg/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Morphine Sulfate | 2 mg/2 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Neostigmine Methylsulfate | 5 mg/5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Neostigmine Methylsulfate | 3 mg/3 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Neostigmine Methylsulfate | 4 mg/4 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Neostigmine Methylsulfate | 3 mg/3 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Nicardipine Hydrochloride | 2.5 g/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | 1 mg/2.5 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-2 | source_no_ndc | 2026-11-14 |